89 related articles for article (PubMed ID: 1781103)
21. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
Wang Y; Iliakis G
Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
[TBL] [Abstract][Full Text] [Related]
22. [Recent advances in gene change of pancreatic cancer].
Wang YY; Cui QC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of the protooncogenes c-myc and c-fos in normal and malignant renal growth.
Vamvakas S; Bittner D; Köster U
Toxicol Lett; 1993 Apr; 67(1-3):161-72. PubMed ID: 8451757
[TBL] [Abstract][Full Text] [Related]
24. Lack of KRAS and BRAF mutation in renal cell carcinoma.
Gattenlöhner S; Etschmann B; Riedmiller H; Müller-Hermelink HK
Eur Urol; 2009 Jun; 55(6):1490-1. PubMed ID: 19282104
[No Abstract] [Full Text] [Related]
25. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
26. DNA mismatch repair genes in renal cell carcinoma.
Deguchi M; Shiina H; Igawa M; Kaneuchi M; Nakajima K; Dahiya R
J Urol; 2003 Jun; 169(6):2365-71. PubMed ID: 12771799
[TBL] [Abstract][Full Text] [Related]
27. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
Jin Y; Burns FJ; Garte SJ
Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma.
Nakajima K; Sasaki M; Nojima D; Oh BR; Ishii N; Miura K; Dahiya R
J Urol; 2001 Feb; 165(2):612-5. PubMed ID: 11176446
[TBL] [Abstract][Full Text] [Related]
29. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
30. DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
Greene DR; Taylor SR; Aihara M; Yoshida K; Egawa S; Park SH; Timme TL; Yang G; Scardino PT; Thompson TC
Int J Cancer; 1995 Jan; 60(3):395-9. PubMed ID: 7829250
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of transforming growth factor-alpha in hereditary rat renal cell carcinoma.
Walker C; Everitt J; Freed JJ; Knudson AG; Whiteley LO
Cancer Res; 1991 Jun; 51(11):2973-8. PubMed ID: 2032234
[TBL] [Abstract][Full Text] [Related]
32. De novo papillary renal cell carcinoma in an allograft kidney: evidence of donor origin.
Naruke Y; Ito M; Mihara Y; Umezaki Y; Matsuya F; Hayashi M; Nakashima M; Khono S
Pathol Int; 2011 Nov; 61(11):694-6. PubMed ID: 22029684
[No Abstract] [Full Text] [Related]
33. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
34. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
[TBL] [Abstract][Full Text] [Related]
35. [Molecular genetic aspects of solid tumors. Presentation of modern study approaches exemplified by renal cell cancer].
Strohmeyer T; Ackermann R
Med Klin (Munich); 1993 Jan; 88(1):28-34. PubMed ID: 8094882
[No Abstract] [Full Text] [Related]
36. [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma].
Li DC
Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):30-2. PubMed ID: 1396043
[TBL] [Abstract][Full Text] [Related]
37. [Tumor suppressor genes associated with development of human renal cell carcinoma].
Morita R; Hikiji K; Yamakawa K; Nakamura Y
Nihon Rinsho; 1992 Dec; 50(12):3100-5. PubMed ID: 1491460
[TBL] [Abstract][Full Text] [Related]
38. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
Yao M; Shuin T; Misaki H; Kubota Y
Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
[TBL] [Abstract][Full Text] [Related]
39. Molecular Determinants of Metastasis in Renal Cell Cancer: Tracking Down the Real Killer.
Lee RJ
J Urol; 2015 Aug; 194(2):278-9. PubMed ID: 25986511
[No Abstract] [Full Text] [Related]
40. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
Mikami S; Mizuno R; Kosaka T; Saya H; Oya M; Okada Y
Int J Cancer; 2015 Apr; 136(7):1504-14. PubMed ID: 25123505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
